unknown
Stage
About
Batea Oncology develops GlioHook, a class III medical device designed to improve treatment outcomes for glioblastoma by concentrating residual tumor cells after surgery and enhancing their sensitivity to radiotherapy.
Explore Batea Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.